Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Net Margin (2009 - 2026)

Updated

Regeneron Pharmaceuticals (REGN) recorded Net Margin of 30.23% in Q2 2026, down 7.63 percentage points from 37.86% a year earlier but up 10.06 percentage points from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Net Margin (2009 - 2026) Analysis & Trends

On a TTM basis, Regeneron Pharmaceuticals' Net Margin came in at 27.86% as of Jun 30, 2026, down 3.50 percentage points year-over-year; for FY2025, it was 31.41%, up 0.34 percentage points from FY2024.

  • Annual Net Margin has a five-year change of -9.94 percentage points (FY2020 to FY2025).
  • Across earlier years, Net Margin came in at 31.07% in FY2024 (+0.93 pp), 30.14% in FY2023 (-5.50 pp), 35.64% in FY2022 (-14.61 pp) and 50.25% in FY2021 (+8.90 pp).
  • Quarterly Net Margin has ranged from 20.17% in Q1 2026 to 47.27% in Q3 2021 over the past five years.
  • On a year-over-year basis, Net Margin has declined for three consecutive quarters, with an average year-over-year change of -2.01 percentage points over the last eight quarters.
  • Peak year-over-year performance for Net Margin in the last five years was a gain of 10.56 percentage points in Q3 2021, against a drop of 30.48 percentage points in Q2 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at 20.17% (Q1 2026), 21.74% (Q4 2025) and 38.89% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 21.86%
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 21.27%
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -8.04%
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 22.65%
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 16.30%
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -134.51%
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -1.65%
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn 30.23%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.23%
Mar 31, 2026 20.17%
Dec 31, 2025 21.74%
Sep 30, 2025 38.89%
Jun 30, 2025 37.86%
Mar 31, 2025 26.70%
Dec 31, 2024 24.22%
Sep 30, 2024 36.03%
Jun 30, 2024 40.38%
Mar 31, 2024 22.96%
Dec 31, 2023 33.77%
Sep 30, 2023 29.97%
Jun 30, 2023 30.66%
Mar 31, 2023 25.86%
Dec 31, 2022 35.06%
Sep 30, 2022 44.81%
Jun 30, 2022 29.82%
Mar 31, 2022 32.83%
Dec 31, 2021 45.01%
Sep 30, 2021 47.27%
API Access

Regeneron Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=REGN&period=max&api_key=YOUR_API_KEY